Prime Therapeutics closes $1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise
EAGAN, Minn. – Dec. 5, 2022 – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today finalized the previously announced acquisition of Magellan Rx…Read More
Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes
EAGAN, Minn. – Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3 entered into a definitive agreement with Centene Corporation to acquire Magellan Health,…Read More
EAGAN, Minn. – Prime Therapeutics LLC (Prime) announced today that they will begin administering Medicare Part D business pharmacy benefits for ClearStone Solutions (ClearStone), effective…Read More
Select a News Category
In the news
Get in touch.
Connect with one of our media experts to learn more about the latest news and trends in the pharmacy benefit management industry.